BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
So I think, you know, we should consider including Dervalumab now in the neoadjuvant setting and in the adjuvant setting.
0
💬
0
Comments
Log in to comment.
There are no comments yet.